Ron Bentsur

CIK: 0001251213

Transaction Breakdown

Open Market Buys (P)4 (22.2%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)6 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

NVCT

Nuvectis Pharma, Inc.

DirectorOfficer10% Owner

XAIR

Beyond Air, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (18 total)

NVCT
Nuvectis Pharma, Inc.
Jun 30, 2026
Purchase(P)
Direct
12.5K shares at avg. $20.00$250K
NVCT
Nuvectis Pharma, Inc.
Jan 6, 2026
Award(A)
Direct
150K shares-
NVCT
Nuvectis Pharma, Inc.
Nov 5, 2025
Purchase(P)
Direct
5K shares at avg. $5.72$29K
NVCT
Nuvectis Pharma, Inc.
Jan 2, 2025
Award(A)
Direct
250K shares-
NVCT
Nuvectis Pharma, Inc.
Dec 24, 2024
Purchase(P)
Direct
4.5K shares at avg. $4.65$21K
XAIR
Beyond Air, Inc.
Nov 22, 2024
Disposition(D)
Stock Options (Right to buy)
Direct
30K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Award(A)
Stock Options (Right to buy)
Direct
30K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Disposition(D)
Stock Options (Right to buy)
Direct
25K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Award(A)
Stock Options (Right to buy)
Direct
25K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Disposition(D)
Stock Options (Right to buy)
Direct
25K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Award(A)
Stock Options (Right to buy)
Direct
25K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Disposition(D)
Stock Options (Right to buy)
Direct
24K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Award(A)
Stock Options (Right to buy)
Direct
24K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Disposition(D)
Stock Options (Right to buy)
Direct
45K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Award(A)
Stock Options (Right to buy)
Direct
45K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Disposition(D)
Stock Options (Right to buy)
Direct
40K shares-
XAIR
Beyond Air, Inc.
Nov 22, 2024
Award(A)
Stock Options (Right to buy)
Direct
40K shares-
NVCT
Nuvectis Pharma, Inc.
Nov 15, 2024
Purchase(P)
Direct
20K shares at avg. $4.92$98K

		Type	Shares	Price		Ownership
Jun 30, 2026	NVCT Nuvectis Pharma, Inc.	Purchase(P)	12,500	$20.00	$250,000	Direct
Jan 6, 2026	NVCT Nuvectis Pharma, Inc.	Award(A)	150,000	-	$0	Direct
Nov 5, 2025	NVCT Nuvectis Pharma, Inc.	Purchase(P)	5,000	$5.72	$28,600	Direct
Jan 2, 2025	NVCT Nuvectis Pharma, Inc.	Award(A)	250,000	-	$0	Direct
Dec 24, 2024	NVCT Nuvectis Pharma, Inc.	Purchase(P)	4,500	$4.65	$20,925	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	30,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	30,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	25,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	25,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	25,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	25,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	24,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	24,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	45,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	45,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Disposition(D) Stock Options (Right to buy)	40,000	-	-	Direct
Nov 22, 2024	XAIR Beyond Air, Inc.	Award(A) Stock Options (Right to buy)	40,000	-	-	Direct
Nov 15, 2024	NVCT Nuvectis Pharma, Inc.	Purchase(P)	20,000	$4.92	$98,400	Direct

1-18 of 18 transactions

About BENTSUR RON

BENTSUR RON (SEC CIK 0001251213) files insider reports with the SEC as Chairman & CEO of Nuvectis Pharma, Inc. (NVCT) and Director of Beyond Air, Inc. (XAIR).

Signal8 holds 7 ownership filings by BENTSUR RON, all Form 4s, filed between Nov 18, 2024 and Jul 1, 2026. Those filings report 18 transactions, from Nov 15, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BENTSUR RON's filings is in FORT LEE, NJ.

Recent filings by BENTSUR RON

Jun 30, 2026: Open-market purchase of NVCT shares (Form 4, code P).
Jan 6, 2026: Grant or award of NVCT shares (Form 4, code A).
Nov 5, 2025: Open-market purchase of NVCT shares (Form 4, code P).
Jan 2, 2025: Grant or award of NVCT shares (Form 4, code A).
Dec 24, 2024: Open-market purchase of NVCT shares (Form 4, code P).

Other insiders filing for Nuvectis Pharma, Inc. (NVCT)

Carson Michael J., Vice President, Finance
Mosseri Marlio Charles, 10% Owner
Hoberman Kenneth, Director
Oliviero James F III, Director
Sanchez Juan, Director
Kaplan Matthew L., Director

How to read Form 4 transaction codes